Your browser doesn't support javascript.
loading
Effect of CYP3A inhibitors on the pharmacokinetics of pevonedistat in patients with advanced solid tumours.
Faessel, Hélène; Nemunaitis, John; Bauer, Todd M; Lockhart, A Craig; Faller, Douglas V; Sedarati, Farhad; Zhou, Xiaofei; Venkatakrishnan, Karthik; Harvey, R Donald.
Afiliación
  • Faessel H; Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
  • Nemunaitis J; University of Toledo, Toledo, OH, USA.
  • Bauer TM; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN, USA.
  • Lockhart AC; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, USA.
  • Faller DV; Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
  • Sedarati F; Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
  • Zhou X; Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
  • Venkatakrishnan K; Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
  • Harvey RD; Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Br J Clin Pharmacol ; 85(7): 1464-1473, 2019 07.
Article en En | MEDLINE | ID: mdl-30845347
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirimidinas / Protocolos de Quimioterapia Combinada Antineoplásica / Ciclopentanos / Inhibidores del Citocromo P-450 CYP3A / Neoplasias Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Clin Pharmacol Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirimidinas / Protocolos de Quimioterapia Combinada Antineoplásica / Ciclopentanos / Inhibidores del Citocromo P-450 CYP3A / Neoplasias Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Clin Pharmacol Año: 2019 Tipo del documento: Article